Melanotan II is a synthetic analogue of the peptide hormone α-melanocyte-stimulating hormone (α-MSH) that stimulates melanogenesis.
It was under development as drug candidate for female sexual dysfunction and erectile dysfunction but clinical development ceased by 2003, and as of 2018, no product containing melanotan II was marketed and all commercial development had ceased.[1]
Melanotan II Peptide is under active investigation in a number of cell culture and animal models.
Our Melanotan II Peptide is stored and handled according to industry guidelines to ensure stability.